Nawata M - Search Results

1

Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission.

Nawata M, Saito K, Nakayamada S, Tanaka Y. Nawata M, et al. Mod Rheumatol. 2008;18(5):460-4. doi: 10.1007/s10165-008-0089-1. Epub 2008 Jun 6. Mod Rheumatol. 2008. PMID: 18535759 Clinical Trial.

2

Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study.

Hirata S, Saito K, Kubo S, Fukuyo S, Mizuno Y, Iwata S, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y. Hirata S, et al. Among authors: nawata m. Arthritis Res Ther. 2013 Sep 25;15(5):R135. doi: 10.1186/ar4315. Arthritis Res Ther. 2013. PMID: 24286472 Free PMC article.

3

Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study.

Katsuyama T, Saito K, Kubo S, Nawata M, Tanaka Y. Katsuyama T, et al. Among authors: nawata m. Arthritis Res Ther. 2014 Feb 5;16(1):R43. doi: 10.1186/ar4472. Arthritis Res Ther. 2014. PMID: 24495443 Free PMC article.

4

Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.

Takeuchi T, Tanaka Y, Amano K, Hoshi D, Nawata M, Nagasawa H, Sato E, Saito K, Kaneko Y, Fukuyo S, Kurasawa T, Hanami K, Kameda H, Yamanaka H. Takeuchi T, et al. Among authors: nawata m. Rheumatology (Oxford). 2011 Oct;50(10):1908-15. doi: 10.1093/rheumatology/ker221. Epub 2011 Jul 13. Rheumatology (Oxford). 2011. PMID: 21752873 Free PMC article.

5

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.

Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Suzuki K, Tanaka Y. Iwata S, et al. Among authors: nawata m. Rheumatology (Oxford). 2009 Aug;48(8):1012-3. doi: 10.1093/rheumatology/kep126. Epub 2009 May 22. Rheumatology (Oxford). 2009. PMID: 19465589 Clinical Trial. No abstract available.

6

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).

Takeuchi T, Yamanaka H, Inoue E, Nagasawa H, Nawata M, Ikari K, Saito K, Sekiguchi N, Sato E, Kameda H, Iwata S, Mochizuki T, Amano K, Tanaka Y. Takeuchi T, et al. Among authors: nawata m. Mod Rheumatol. 2008;18(5):447-54. doi: 10.1007/s10165-008-0077-5. Epub 2008 May 21. Mod Rheumatol. 2008. PMID: 18493716

7

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM).

Yamanaka H, Tanaka Y, Sekiguchi N, Inoue E, Saito K, Kameda H, Iikuni N, Nawata M, Amano K, Shinozaki M, Takeuchi T. Yamanaka H, et al. Among authors: nawata m. Mod Rheumatol. 2007;17(1):28-32. doi: 10.1007/s10165-006-0532-0. Epub 2007 Feb 20. Mod Rheumatol. 2007. PMID: 17278019

8

Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody.

Nishida K, Okada Y, Nawata M, Saito K, Tanaka Y. Nishida K, et al. Among authors: nawata m. Endocr J. 2008 Mar;55(1):213-6. doi: 10.1507/endocrj.k07e-043. Epub 2008 Feb 13. Endocr J. 2008. PMID: 18270431 Clinical Trial.

9

Efficacy of mizoribine treatment in patients with Sjögren's syndrome: an open pilot trial.

Nakayamada S, Saito K, Nakatsuka K, Nakano K, Tokunaga M, Sawamukai N, Tsujimura S, Nawata M, Tanaka Y. Nakayamada S, et al. Among authors: nawata m. Mod Rheumatol. 2003 Dec;13(4):339-45. doi: 10.3109/s10165-003-0247-4. Mod Rheumatol. 2003. PMID: 24387256

10

Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study.

Kubo S, Saito K, Hirata S, Fukuyo S, Yamaoka K, Sawamukai N, Nawata M, Iwata S, Mizuno Y, Tanaka Y. Kubo S, et al. Among authors: nawata m. Mod Rheumatol. 2014 Jan;24(1):42-51. doi: 10.3109/14397595.2013.854051. Mod Rheumatol. 2014. PMID: 24261758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results